Indications and uses
For the prevention and treatment of the nausea, vomiting, or dizziness associated with motion sickness.
For the prevention and treatment of the nausea, vomiting, or dizziness associated with motion sickness.
do not use more than directed to prevent motion sickness, take the first dose one hour before starting activity Adults and children: (12 years and older) 1 to 2 tablets once daily or as directed by a doctor. Do not exceed 2 tablets in 24 hours. Children under 12 years: Do not give to children under 12 years of age.
Drug Facts
Meclizine Hydrochloride 25 mg
Antiemetic
For the prevention and treatment of the nausea, vomiting, or dizziness associated with motion sickness.
Do not exceed recommended dosage.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children: (12 years and older) 1 to 2 tablets once daily or as directed by a doctor. Do not exceed 2 tablets in 24 hours.
Children under 12 years: Do not give to children under 12 years of age.
anhydrous lactose, colloidal silicon dioxide, corn starch, D&C yellow # 10, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
1-800-634-7680
Product: 50090-4493
NDC: 50090-4493-0 2 TABLET in a PACKET / 500 in a BOX
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-4493-0 | 2023-01-30 | C162847 | 48780-1 | f386c649-c361-0266-e053-dadaa90a7c1a | d7419e82-55d7-4699-a2d5-c45c54f845c7 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4493-0 | Medique Medi-Meclizine | 500 in 1 BOX | TABLET | 500 | 3 | |
| 50090-4493-0 | Medique Medi-Meclizine | 2 in 1 PACKET | TABLET | 2 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4493 | MEDIQUE MEDI-MECLIZINE (MECLIZINE HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS] | 3 | Legacy NDC, 2 package rows | 20210417_d7419e82-55d7-4699-a2d5-c45c54f845c7.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50090-4493 | 50090-4493-0 |
| 47682-480 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| D&C YELLOW NO. 10 | 35SW5USQ3G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 81f218cb-345b-4f3f-8aff-bdc40d0bc9a3 | d7419e82-55d7-4699-a2d5-c45c54f845c7 | 2021-04-15 | Warnings | 81f218cb-345b-4f3f-8aff-bdc40d0bc9a3 d7419e82-55d7-4699-a2d5-c45c54f845c7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.